
Drugmakers raise US prices on 350 medicines as Trump's pressure collides with the pricing system
As of December 31, 2025, drugmakers are preparing to raise list prices in the United States for at least 350 branded medicines, starting January 1, 2026. The moves land in the middle of a political campaign to show relief for everyday costs, and they put the spotlight back on why US drug prices remain so difficult to steer.
The immediate tension is simple. The White House is pushing companies to cut what Americans pay. Yet manufacturers are still lifting published prices across vaccines, cancer drugs, and common therapies. Some firms are also cutting prices on a small set of medicines at the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.